Srne Ltd Abg serves as Executive at Sorrento Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Srne Ltd Abg has executed 2 insider transactions totaling $5.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 13, 2017 involved purchasing 1,500,000 shares valued at $3.0M.
Srne Ltd Abg currently holds 1,500,000 shares of Sorrento Therapeutics, Inc. (SRNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Srne Ltd Abg has been a net buyer of SRNE stock. They have purchased $5.0M and sold $0 worth of shares.
Srne Ltd Abg's most recent insider trade was on Apr 13, 2017, when they purchased 1,500,000 shares at $2.00 per share.
Get notified when new Form 4 filings are submitted
| $2.00 |
| Discretionary |